Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Procter & Gamble Health

Market Cap: ₹113.4b

Manufactures and markets pharmaceuticals and chemical products in India and internationally.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹412.6b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

Pharma Mar

Market Cap: €1.4b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.

Abbott India

Market Cap: ₹576.4b

Operates as a pharmaceutical company in India.

BioGaia

Market Cap: SEK 11.8b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Rigel Pharmaceuticals

Market Cap: US$787.3m

A biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.

Highnoon Laboratories

Market Cap: PK₨54.1b

Together with its subsidiary, engages in the development, production, marketing, and distribution of pharmaceutical and allied consumer products in Pakistan, Afghanistan, the United Arab Emirates, Sri Lanka, France, Sudan, Cambodia, Kenya, Iraq, Dubai, Tanzania, and internationally.

SK Biopharmaceuticals

Market Cap: ₩6.5t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

Exelixis

Market Cap: US$14.2b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س10.3b

Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

Consun Pharmaceutical Group

Market Cap: HK$11.4b

Produces and sells pharmaceutical products in Mainland China.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥55.3b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.

DHG Pharmaceutical

Market Cap: ₫12.2t

Engages in the manufacture and sale of pharmaceutical products in Vietnam.

Chugai Pharmaceutical

Market Cap: JP¥12.2t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Catalyst Pharmaceuticals

Market Cap: US$3.9b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Gubra

Market Cap: DKK 5.8b

A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.

Samsung BiologicsLtd

Market Cap: ₩64.6t

Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

Acutaas Chemicals

Market Cap: ₹278.4b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.